ABMT (Advanced BioMedical Technologies) Total Stockholders Equity: $-8.18 Mil (As of Jul. 2021)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Advanced BioMedical Technologies Total Stockholders Equity?

Advanced BioMedical Technologies ABMT Total Stockholders Equity is $-8.18 Mil as of Jul. 2021.

Advanced BioMedical Technologies's Total Stockholders Equity for the quarter that ended in Jul. 2021 was $-8.18 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Advanced BioMedical Technologies's Book Value per Share for the quarter that ended in Jul. 2021 was $-0.12. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Advanced BioMedical Technologies's Debt-to-Equity for the quarter that ended in Jul. 2021 was -0.00.

Advanced BioMedical Technologies  (OTCPK:ABMT) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Advanced BioMedical Technologies's Book Value per Share for the quarter that ended in Jul. 2021 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-8.182-0)/70.225
=-0.12

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Advanced BioMedical Technologies's Debt-to-Equity for the quarter that ended in Jul. 2021 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.011 + 0) / -8.182
=-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced BioMedical Technologies Total Stockholders Equity Related Terms

Advanced BioMedical Technologies Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Advanced BioMedical Technologies's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced BioMedical Technologies Total Stockholders Equity Chart

Advanced BioMedical Technologies Annual Data
Trend Oct11 Oct12 Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.36 -5.00 -5.62 -6.48 -7.40

Advanced BioMedical Technologies Quarterly Data
Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.99 -7.40 -7.83 -7.97 -8.18
What does a Total Stockholders Equity of $-8.18 Mil mean?
Advanced BioMedical Technologies (ABMT) has a Total Stockholders Equity of $-8.18 Mil as of Jul. 2021. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Advanced BioMedical Technologies and its competitors.
Is Advanced BioMedical Technologies' Total Stockholders Equity too high?
Advanced BioMedical Technologies' current Total Stockholders Equity is $-8.18 Mil.
How does Advanced BioMedical Technologies' Total Stockholders Equity compare to VYCO and ADMT?
Advanced BioMedical Technologies' Total Stockholders Equity of $-8.18 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Devices & Instruments company?
A good Total Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Advanced BioMedical Technologies and its competitors. Advanced BioMedical Technologies's current Total Stockholders Equity is $-8.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced BioMedical Technologies stock overvalued right now?
Advanced BioMedical Technologies (ABMT) has a current Total Stockholders Equity of $-8.18 Mil. The current Total Stockholders Equity is $-8.18 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Advanced BioMedical Technologies (ABMT), the current Total Stockholders Equity is $-8.18 Mil as of Jul. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advanced BioMedical Technologies Business Description

Address 535 Fifth Avenue, 4th Floor, New York, NY, USA, 10017
Advanced BioMedical Technologies Inc is engaged in designing, developing, manufacturing, and the planned future marketing of self-reinforced, re-absorbable, biodegradable internal fixation devices. The company manufactures its products using Polyamide, and it is used in a variety of applications, which include orthopaedic trauma, sports-related medical treatment, cartilage injuries, and reconstructive dental procedures. Its Polyamide products include screws, rods, and binding wires consisting of enhanced fibres and high molecular polymers, which are designed to facilitate quick healing of complex fractures in many areas of the human skeletal system.